PATLY.AIApplication
19611687 · COMBINATION OF THE AXL INHIBITOR SLC-391 AND A PD-1 INHIBITOR FOR USE IN THE TREATMENT OF BLOOD CANCER
Filed 2026-07-31 · Pending The official file ↗ · Art unit · SIGNALCHEM LIFESCIENCES CORPORATION · SEED INTELLECTUAL PROPERTY LAW GROUP LLP
Office actions
0
first was
RCEs
0
no appeal
To first action
n/a
to disposition n/a
Statutes raised
·
0 actions read